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SummARy – enhanced recovery after surgery (eRAS) programs are perioperative evidence-
based interventions that have the purpose of making the perioperative pathway more efficient in 
safeguarding patient safety and quality of care. Recently, several eRAS components have been intro-
duced in the setting of bariatric surgery (enhanced Recovery After Bariatric Surgery, eRABS). The 
aim of the present study was to evaluate clinical efficiency and cost-effectiveness of the implementa-
tion of an eRABS program. It was a retrospective case-control study comparing a group of adult obese 
(body mass index >40) patients treated according to the eRABS protocol (2014-2015) with a his-
torical control group that received standard care (2013-2014) in the general and emergency Surgery 
department, Arcispedale S. maria nuova hospital, Reggio emilia, Italy. data on the occurrence of 
complications, mortality, re-admissions and re-operations were extracted retrospectively from medical 
case notes and emergency patient admission lists. length of hospital stay was significantly different 
between the two cohort patients. In the control group, the mean length of stay was 12.6±10.9 days, 
whereas in the eRABS cohort it was 7.1±2.9 days (p=0.02). during hospital stay, seven patients in the 
control group developed surgical complications, including one patient with major complications, 
whereas in the eRABS group three patients developed minor complications. economic analysis 
 revealed a different cost distribution between the two groups. On the whole, there were significant 
savings for almost all the variables taken into consideration, mainly driven by exclusion of using inten-
sive care unit, which is by far more expensive than the average cost of post-anesthesia care unit. Our 
study confirmed the implementation of an eRABS protocol to have shortened hospital stay and was 
cost-saving while safeguarding patient safety.
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Introduction
The escalating global epidemic of obesity all over 
the world challenges allocation of national healthcare 
resources1. Bariatric surgery is the most effective treat-
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ment for severe obesity, resulting in durable weight 
loss, as well as a positive impact on obesity-related co-
morbidities. As a result of the epidemic, the rate of 
surgical procedures worldwide increased from 146,000 
in 2003 to 340,000 in 2011, with Roux-en-y gastric 
bypass (RygB) and sleeve gastrectomy accounting for 
75% of all treatments2. The increased demand for bar-
iatric surgery in the context of limited economic re-
sources enforces adoption of good clinical practice 
guidelines aimed at optimizing the peri- and postop-
erative care of these patients3. enhanced recovery after 
surgery (eRAS) programs are perioperative evidence-
based interventions that have the purpose of making 
more efficient the perioperative pathway safeguarding 
patient safety and quality of care. eRAS pathways are 
designed to put the patient in the best possible condi-
tions to deal with surgery, reduce surgical stress, and 
quickly bring it back to wellness4. eRAS programs, 
when implemented successfully, have resulted in a re-
duced length of hospital stay (lOS), reduced compli-
cations and better quality of life outcomes5-7. Recently, 
several eRAS components have been introduced in 
the setting of bariatric surgery (enhanced Recovery 
After Bariatric Surgery, eRABS), and dedicated 
guidelines have been published8. however, although 
there are several studies documenting the feasibility of 
eRABS, the evidence for clinical efficiency and cost-
effectiveness is limited. The aim of the present study 
was to evaluate clinical efficiency and cost-effective-
ness of the implementation of an eRABS program.
Patients and Methods
This was a retrospective case-control study com-
paring a group of adult obese (body mass index, (BmI) 
>40) patients treated according to the eRABS proto-
col (2014-2015) with a historical control group that 
received standard care (2013-2014) in the general and 
emergency Surgery department, Arcispedale S. ma-
ria nuova hospital, Reggio emilia, Italy. The study 
was approved by the Institutional Review Board of the 
Arcispedale S. maria nuova, Reggio emilia (protocol 
no. 2016/0014694). All patient data such as demo-
graphic details, baseline comorbidities, operations per-
formed and lOS were obtained from the electronic 
hospital clinical database of surgical interventions 
(easysalo® uniCOde srl Software engineering). The 
matching parameters were sex, age, BmI and comor-
bidities, and American Society of Anesthesiologists 
(ASA) physical status. The only exclusion criterion for 
both groups was patient refusal to participate in the 
study. The evaluation of cost variables (table 1) was 
done in accordance with data provided by the hospi-
tal. data on the occurrence of complications (in ac-
cordance with Clavien-dindo classification)9, mortal-
ity, re-admissions and re-operations were extracted 
retrospectively from medical case notes and emergency 
patient admission lists.
Table 1. Cost per variables
variable description
Personnel cost Cost per patient/minute




total lOS cost per patient/day
ICu lOS cost Cost per patient/day in ICu
PACu cost Cost per patient/day in PACu
Overhead cost total cost per patient/minute
lOS = length of stay; ICu = Intensive Care unit; PACu = Post-
Anesthesia Care unit
Patients in the eRABS group had their periopera-
tive care managed according to the eRAS guidelines, 
while the control group followed the standard care es-
tablished by the department protocols. Patients in the 
eRABS and control groups were discharged once they 
had fulfilled the predetermined, standardized dis-
charge criteria (table 2). decision on discharge was 
made by medical staff of the hospital that were not 
involved in the study. The primary outcome was the 
mean lOS. Secondary outcomes included postopera-
tive morbidity and mean cost per patient.
Table 2. Discharge criteria
Adequate pain relief with oral non-opioid analgesia 
(paracetamol and etoricoxib)
no evidence for wound dehiscence or wound infection
no postoperative complication
Pulse rate <90 beats/min, temperature ≤37.6 °C, 
respiratory rate <20 breaths/min
uneventful technical procedure 
Patient ambulatory
drank 1 liter of water within 24 h
tolerating free oral fluids (e.g., milk)
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Statistical analysis
Continuous data are reported as mean ± standard 
deviation (range) and were compared using Wilcoxon-
mann-Whitney test. differences between the two 
groups for continuous variables were analyzed with 
Wilcoxon-mann-Whitney test, while differences in 
dummy variables were analyzed with fisher exact test. 
Statistical significance was set at p<0.05. Statistical 
analyses were performed using IBmSPSS Statistics 
for Windows, version 19.0 (IBm Corp., Armonk, ny, 
uSA).
Economic analysis
We carried out economic analysis by classifying 
different cost centers where the patient was involved. 
The model uses time as the independent variable to 
define the value of the others, allowing to estimate the 
mean cost per minute for each variable taken into con-
sideration. We assumed as given the mean cost of ma-
terial (provided by the Arcispedale S. maria nuova 
administration and control board). furthermore, the 
mean overhead cost per minute was obtained using the 
overall yearly overhead cost divided by the total utili-
zation time of the operating theater. Regarding the 
staffing level and shifts, we estimated an average time 
and mix presence of personnel based on interviews 
conducted with medical staff. The results were used as 
baseline for the model assumptions, as follows:
•	 2 surgeons = real time recorded by easySalo 
Software
•	 2 nurses = time allocated equaled the time of 
surgery
•	 1 anesthesiologist = real time recorded by ea-
sySalo Software
•	 1 nursing assistive staff = time allocated equaled 
the time of surgery
While we had to impute different absorption of re-
sources in order to estimate the total Operating The-
ater Cost, all other elements within the process (such 
as Intensive Care unit (ICu), Post-Anesthesia Care 
unit (PACu) and ward) were average costs given by 
the hospital and already including utilization of dif-
ferent resources per patient. nevertheless, the latter 
were adjusted as the function of time in order to be 
included in the model. Overall, the model allowed to 
highlight both the cost configuration and variable 
weights in the two different pathways and was de-
signed as shown in figure 1.
Results
There was no statistically significant difference at 
baseline between the two groups of patients for any 
study variable (table 3). lOS was significantly differ-
ent between the two patient cohorts. In the control 
group, the mean lOS was 12.6±10.9 days, while in the 
eRABS group it was 7.1±2.9 days (p=0.02).
Fig. 1. Cost formula.
Table 3. Baseline demographic and comorbidity variables
variable Control group eRABS group p value
Patients, n 26 25
female patients, n (%) 16 (61.5) 21 (80.8) 0.070*
Age (yrs), mean (Sd) 46 (10) 41 (11) 0.146**
BmI, mean (Sd) 50.4 (5.8) 48 (7.7) 0.208**
hypertension, n (%) 11 (42.3) 10 (38.5) 0.785*
OSAS, n (%) 6 (23.1) 5 (20) 0.801*
COPd, n (%) 6 (23.1) 2 (8) 0.147*
diabetes type 2, n (%) 5 (19.2) 6 (24) 0.691*
Smoker, n (%) 5 (19.2) 6 (24) 0.691*
Sd = standard deviation; BmI = body mass index; OSAS = obstruction sleep apnea syndrome; COPd = chronic ob-
structive pulmonary disease; eRABS = enhanced Recovery After Bariatric Surgery; *u mann-Whitney test; **t-test
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during lOS, seven subjects in the control group 
developed surgical complications; one of them suffered 
major complication, Clavien-dindo classification 3b, 
while in the eRABS group three patients developed 
minor complications, all classified as grade 2 of the 
Clavien-dindo classification (table 4).
economic analysis revealed different cost distribu-
tion in the two groups. A greater proportion of the cost 
was generated by ICu stay and the associated person-
nel time and by material usage in the control group 
(fig. 2). Another difference between the two groups 
Table 4. Hospital stay and postoperative complications
eRABS Control p value







*Wilcoxon-mann-Whitney test; **fisher exact test; eRABS = en-
hanced Recovery After Bariatric Surgery
Fig. 3. Savings per variable in Enhanced Recovery After 
Bariatric Surgery, ERABS). vs. control group.
Fig. 2. Cost distribution.
was related to the cost generated by PACu stay, which 
was higher in the eRABS group. On the whole, as 
shown in figure 3, there were significant savings for 
almost all the study variables, mainly driven by exclu-
sion of the use of ICu, the latter being by far more 
expensive than the average cost of PACu. The share of 
savings brought in by the new procedure compared 
with the control group was remarkable, reaching a to-
tal average of 5743 € saved per procedure. As shown in 
figure 3, positive saving was recorded in four out of 
the six variables analyzed (overhead cost remained 
stable, accounting for only 1% of the total cost along 
with the material average total cost). It is important to 
mention that, although the material average total cost 
variable in our analysis was assumed as constant, real-
ity suggests that the cost of material might increase 
slightly when using the new procedure.
Discussion
In the eu countries, health expenditure has been 
growing faster than the national income10,11. This can 
be attributed to the demand and supply side factors of 
population aging and medical innovation. The process 
of transforming resources into health outcomes is not 
efficient and it works as a factor contributing to the 
excessive growth of health expenditure. The use and 
application of efficiency concepts and programs to 
healthcare systems is not easy and sometimes it does 
not have an immediate impact on health outcomes. 
The application of eRAS protocols has a direct posi-
tive impact on performance of the healthcare services 
in terms of clinical quality indicators12. The implemen-
tation of eRAS principles in the bariatric surgery set-
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tings has demonstrated the same positive clinical im-
pact13, but evidence for the cost-saving effect is limited. 
In our study, the introduction of an evidence based 
protocol for perioperative care of obese patients eligi-
ble for bariatric surgery has allowed significant reduc-
tion of hospital stay and associated costs by improving 
the efficiency safeguarding patient safety. Some limita-
tions of the study should be emphasized in addition to 
its retrospective design. Cost trends over time were not 
included in the analysis, which was delimited to the 
2015 cost report. This did not allow to take into con-
sideration ongoing trends of surgery time reductions 
(which would result in cost reduction), if any. We esti-
mated the time of surgery matched to the time im-
puted to nurses within the operating theater. however, 
this did not take into consideration differences that 
might occur in the awakening time after surgery. The 
sample size was small because of the large proportion 
of cases still treated with the traditional approach. 
Caution is therefore necessary in drawing conclusions 
on complications. Our study showed the implementa-
tion of the new protocol (eRABS) to have ensured 
significant saving in four out of the six variables taken 
into consideration. greater saving was obtained by 
preventing patient admission to the ICu, which was 
the most costly patient pathway step.
Conclusions
Our study confirmed that the implementation of the 
eRABS protocol shortened hospital stay and was cost-
saving safeguarding patient safety. future research 
should investigate the efficacy and safety of systematic 
implementation of this approach, defining the costs as-
sociated with the individual items of the program.
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Sažetak
PRImJenA PROgRAmA uBRZAnOg OPORAvKA nAKOn BARIJAtRIJSKe KIRuRgIJe:  
AnAlIZA KlInIČKIh IShOdA I ISPlAtIvOStI
V. Agnoletti, S. Bonilauri, L. De Pietri, D. Ferrara, A. Lanaia, N. Pipia, M. Seligardi, E. Padovani i R. M. Corso
Programi ubrzanog oporavka nakon operacije (Enhanced Recovery After Surgery, eRAS) su perioperacijske intervencije 
zasnovane na dokazima kojima je svrha učiniti perioperacijski tijek učinkovitijim osiguravajući bolesnikovu sigurnost i kva-
litetu skrbi. Odnedavno je nekoliko sastavnica programa eRAS uvedeno u okruženje barijatrijske kirurgije (Enhanced Reco-
very After Bariatric Surgery, eRABS). Cilj ovoga istraživanja bio je procijeniti kliničku učinkovitost i isplativost provođenja 
programa eRABS. u ovoj retrospektivnoj studiji slučaja i kontrola uspoređena je skupina odraslih pretilih bolesnika (indeks 
tjelesne mase >40) liječenih prema protokolu eRABS (2014.-2015.) s povijesnom kontrolnom skupinom koja je primala 
standardnu skrb (2013.-2014.) u Klinici za opću i hitnu kirurgiju, Bolnica Arcispedale S. maria nuova, Reggio emilia, Ita-
lija. Podaci o pojavnosti komplikacija, smrtnosti, ponovnom prijmu i ponovljenim operacijama retrospektivno su izvedeni iz 
bolesničkih kartona i prijamnih lista. duljina boravka u bolnici značajno se razlikovala među dvjema skupinama bolesnika. 
u kontrolnoj skupini srednja duljina boravka u bolnici bila je 12,6±10,9 dana, dok je skupini eRABS iznosila 7,1±2,9 dana 
(p=0,02). Kod prijma se kirurška komplikacija razvila u 7 osoba iz kontrolne skupine; od toga je jedan bolesnik imao teže 
komplikacije, dok su u skupini eRABS manje komplikacije zabilježene kod 3 bolesnika. ekonomska analiza pokazala je 
drukčiju raspoređenost troškova u dvjema skupinama. Sve u svemu, značajne uštede u gotovo svim ispitivanim varijablama 
uglavnom su nastale zbog isključenja uporabe jedinice intenzivnog liječenja, što je daleko skuplje od prosječnih troškova u 
jedinici skrbi poslije anestezije. naše je istraživanje potvrdilo da primjena protokola eRABS skraćuje boravak u bolnici i 
snižava troškove pritom osiguravajući sigurnost bolesnika.
Ključne riječi: Bariatrijska kirurgija; Ubrzani oporavak nakon operacije; Troškovi
